Health Catalyst Q3: Mixed Results
Update: 2025-11-11
Description
Health Catalyst reported Q3 2025 earnings, beating revenue estimates but showing no growth compared to last year. The company projects a slight revenue dip in Q4, falling short of analysts expectations. Despite this, adjusted EBITDA significantly exceeded estimates, and free cash flow improved. The stock saw a modest increase post-announcement.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel




